J 2022

Movement disorders, cerebral palsy and vaccination

LIBA, Zuzana, Josef KRAUS, Tomáš NEČAS, Jiri NECAS, Miloslav KLUGAR et. al.

Základní údaje

Originální název

Movement disorders, cerebral palsy and vaccination

Autoři

LIBA, Zuzana (203 Česká republika), Josef KRAUS (203 Česká republika), Tomáš NEČAS (203 Česká republika), Jiri NECAS (203 Česká republika), Miloslav KLUGAR (203 Česká republika, domácí) a Pavel KRSEK (203 Česká republika, garant)

Vydání

European Journal of Paediatric Neurology, OXFORD, ELSEVIER SCI LTD, 2022, 1090-3798

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.100

Kód RIV

RIV/00216224:14110/22:00125125

Organizační jednotka

Lékařská fakulta

UT WoS

000811339200024

Klíčová slova anglicky

Immunization; Vaccination; Movement disorders; Adverse events; Cerebral palsy

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 19. 7. 2022 10:42, Mgr. Tereza Miškechová

Anotace

V originále

This review focused on vaccination in children with movement disorders, including cerebral palsy and the movement disorders triggered by vaccination in children with and without neurological disabilities. The following clinical questions were addressed: 1) Can children with movement disorders be vaccinated? 2) Can vaccination trigger movement disorders in children without neurological disabilities? 3) Can vaccination trigger movement disorders in children with neurological disabilities? and 4) Is there any consensus of care concerning vaccination in children with movement disorders? Following the PRISMA reporting guidelines, 1096 records were identified and 34 relevant papers were included. No evidence that vaccinations are contraindicated for children with movement disorders was noticed. Several reports of neurological adverse events, including movement disorders in children without neurological disabilities after various types of vaccination, were found. The reporting rates were low, the causality was controversial, and patient outcomes were mostly favourable. There was limited (if any) evidence in our search that any vaccination leads to any movement disorder exacerbation. Finally, no generally accepted consensus or standards of care concerning vaccination in patients with movement disorders were found. In summary, we found few precautions for vaccination in this group of patients and concluded that general best practice guidelines for immunization should be followed. In addition, influenza and pneumococcal vaccines are recommended because they can reduce morbidity and mortality in individuals severely affected by movement restrictions.